Patent 8679407 was granted and assigned to Theranos on March, 2014 by the United States Patent and Trademark Office.
This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.